XML 61 R36.htm IDEA: XBRL DOCUMENT
v3.25.1

SEGMENT INFORMATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
SEGMENT INFORMATION |
Schedule of Segment Information |
| b. | Segment information:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
(U.S. dollars in thousands) |  | 2022 |  | 2023 |  | 2024
Revenues from customers |  | $ | 47,638 |  | $ | 65,494 |  | $ | 53,399
Less: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Employee salaries and related expenses | ​ |  | 19,388 | ​ |  | 24,075 | ​ |  | 21,780
Sub-contractors expense | ​ |  | 24,181 | ​ |  | 14,008 | ​ |  | 8,682
interest expense | ​ |  | 2,529 | ​ |  | 3,180 | ​ |  | 1,062
Interest income | ​ | ​ | (1,146) | ​ | ​ | (1,286) | ​ | ​ | (1,299)
Depreciation | ​ | ​ | 1,086 | ​ | ​ | 1,191 | ​ | ​ | 1,304
Other segment expenses* | ​ | ​ | 15,997 | ​ | ​ | 15,760 | ​ | ​ | 17,716
Income before income taxes | ​ | ​ | (14,397) | ​ | ​ | 8,566 | ​ | ​ | 4,154
Taxes on income | ​ | ​ | 530 | ​ | ​ | 254 | ​ | ​ | 1,222
Segment net income | ​ | $ | (14,927) | ​ | $ | 8,312 | ​ | $ | 2,932
​ * Other expenses included in net income includes raw materials, rent and utilities and others.
Schedule of Disaggregation of Revenues |
| c. | The following table summarizes the Company’s disaggregation of revenues:
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Year Ended December 31,
(U.S. dollars in thousands) |  | 2022 |  | ​ | 2023 | ​ | 2024
Gaucher disease: |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pfizer (Ireland) | ​ | $ | 12,403 | ​ | ​ | $ | 12,522 | ​ | $ | 12,617
Fiocruz (Brazil) | ​ | $ | 9,452 | ​ | ​ | $ | 10,401 | ​ | $ | 11,031
Fabry disease: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Chiesi (Italy) | ​ | $ | 3,437 | ​ | ​ | $ | 17,495 | ​ | $ | 29,333
Total revenues from selling goods | ​ | $ | 25,292 | ​ | ​ | $ | 40,418 | ​ | $ | 52,981
Revenues from license and R&D services | ​ | $ | 22,346 | ​ | ​ | $ | 25,076 | ​ | $ | 418

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration